Tag Archives: non metastatic prostate cancer
Combination of Abiraterone and Prednisolone Plus Androgen Deprivation Therapy Demonstrated Improved Survival Outcomes for Patients with Nonmetastatic High-Risk Prostate Cancer
According to the findings from a combined assessment of the multistage trial named STAMPEDE presented during the 2021 European Society […]
